Table 3 Comparison of pro-inflammatory cytokines and brain injury markers by severity of head injury (n = 350) based on the Glasgow coma scale (GCS).
Mild (n = 233) | Moderate (n = 50) | Severe (n = 67) | p value** | |
|---|---|---|---|---|
Routine laboratory | ||||
HsTnT initial | 12 (9.1 to 14.9) | 11.6 (5.5 to 17.6) | 27.5 (14.4 to 40.6) | 0.001 |
HsTnT (repeated after 6 h) (n = 303) | 17.9 (10.6 to 25.1) | 20.7 (9.7 to 31.8) | 71.4 (30.5 to 112.4) | 0.001 |
Serum CRP (n = 339) | 18.1 (14.0 to 22.2) | 29.8 (17.4 to 42.2) | 41.5 (26.5 to 56.4) | 0.01 |
Lactate (n = 343) | 2.6 (2.3 to 2.8) | 3.8 (2.7 to 4.9) | 2.4 (2.1 to 2.7) | 0.02 |
Base deficit (n = 334) | − 0.8 (− 1.3 to 0.2) | − 4.1 (− 5.5 to 2.6) | − 4.2 (− 4.9 to 3.3) | 0.001 |
Pro-inflammatory cytokines | ||||
Interleukin-6 (pg/ml) | ||||
Baseline (on-admission) | 81.2 (58.9 to 103.6) | 117.4 (64.5 to 170.3) | 144.5 (81.3 to 207.7) | 0.001 |
After 24 h† | 75.8 (51.2 to 100.5) | 91.9 (47.5 to 136.5) | 111.9 (69.1 to 154.7) | 0.003 |
After 48 h†† | 90.7 (63.1 to 118.3) | 84.6 (34.1 to 134.9) | 78.1 (38.4 to 117.9) | 0.07 |
p value within the group* | 0.001 | 0.004 | 0.001 | |
Interleukin-18 (pg/ml) | ||||
Baseline (on-admission) | 575.2 (510.8 to 639.6) | 624.8 (502.7 to 746.8) | 500.7 (409.9 to 591.5) | 0.32 |
After 24 h† | 576.9 (495.1 to 657.3) | 634.8 (503.1 to 766.5) | 528.7 (432.3 to 625.1) | 0.29 |
After 48 h†† | 590.7 (501.6 to 679.9) | 518.9 (422.7 to 615.2) | 496.6 (368.7 to 624.5) | 0.57 |
p value within the group | 0.001 | 0.01 | 0.005 | |
Interleukin-1β (pg/ml) | ||||
Baseline (on-admission) | 61.5 (45.9 to 77.1) | 33.9 (19.9 to 47.7) | 75.3 (25.5 to 125.2) | 0.04 |
After 24 h† | 51.9 (36.2 to 67.7) | 61.8 (17.6 to 106.0) | 61.7 (27.9 to 95.5) | 0.33 |
After 48 h†† | 29.6 (24.8 to 34.4) | 32.8 (15.9 to 49.7) | 37.9 (14.9 to 60.9) | 0.56 |
p value within the group* | 0.001 | 0.60 | 0.02 | |
Interleukin-8 (pg/ml) | ||||
Baseline (on-admission) | 429.3 (320.4 to 538.2) | 297.9 (197.9 to 396.5) | 273.8 (193.9 to 353.6) | 0.21 |
After 24 h† | 398.4 (299.9 to 496.9) | 379.9 (260.5 to 499.2) | 410.2 (237.9 to 582.5) | 0.74 |
After 48 h†† | 392.7 (301.4 to 483.9) | 355.8 (242.8 to 468.7) | 354.5 (225.8 to 483.3) | 0.49 |
p value within the group* | 0.009 | 0.80 | 0.25 | |
Epinephrine (pg/ml) | ||||
Baseline (on-admission) | 1308.7 (1148.1 to 1469.2) | 1691.5 (1186.4 to 2196.5) | 1810.5 (1335.2 to 2285.8) | 0.40 |
After 24 h† | 1377.1 (1200.5 to 1553.2) | 1529.8 (1027.2 to 2032.4) | 1761.2 (1351.3 to 2171.1) | 0.43 |
p value within the group* | 0.55 | 0.77 | 0.14 | |
Brain injury markers | ||||
S-100B (pg/ml) at baseline | 439.6 (351.1 to 324.9) | 695.9 (422.9 to 968.8) | 553.1 (287.6 to 818.5) | 0.05 |
Neuron-specific enolase (pg/ml) | ||||
Baseline (on-admission) | 19,253 (16,269 to 22,238) | 23,116 (16,072 to 30,159) | 24,174 (16,339 to 32,008) | 0.40 |
After 24 h† | 16,295 (13,654 to 18,936) | 16,689 (11,492 to 21,887) | 22,977 (16,154 to 29,799) | 0.54 |
After 48 h†† | 15,459 (12,832 to 18,086) | 18,424 (9329 to 27,518) | 21,263 (15,076 to 27,450) | 0.57 |
p value within the group* | 0.001 | 0.001 | 0.37 | |